Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011547

Director sold 2,000 shares at $65.45 ($130,900)

  • Director acquired 2,000 shares (option exercise)
  • Director acquired 1,504 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HERSHBERG ROBERT · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-14 Grant or award : show line 1 in the form +1,504 1,504 D
2021-02-16 Exercise or conversion : show line 2 in the form +2,000 $0.45 $900 3,504 D
2021-02-16 Sale : show line 3 in the form −2,000 $65.45 $130,900 1,504 D
Open-market sales · 2,000 sh · avg $65.45 · $130,900

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-14 Grant or award : show line 4 in the form Stock Option (Right to Buy) +3,759 3,759 D
2021-02-16 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −2,000 55,000 D
Loading xslF345X03/doc4.xml…